| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b095f2ffe7162385d7a1fac05ef02c07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bfb57f2d9d8c6a78e97a49cff650b8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc94005adf6489817da457ba40c83403
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f117ae08c29ea38394504973974151e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-347 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B- |
| filingDate |
2004-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e46b201838f0f536583129ad046f342e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9c69b0d53d554543cb719abf713196f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_396f5b4d85524d9cca6a44daded00766 |
| publicationDate |
2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004112566-A2 |
| titleOfInvention |
Diagnosis and treatment of nephropathy |
| abstract |
This application is directed to a method for the treatment of nephropathy or kidney fibrosis or glomerulosclerosis or chronic renal insufficiency in a subject in need of such treatment comprising administering to said subject an amount of an inhibitor of HNOEL-iso polypeptide sufficient to effect a substantial inhibition of the HNOEL-iso polypeptide so as to thereby treat the subject. This application is also directed to a process of obtaining a compound which inhibits human HNOEL-iso polypeptide This application is also directed to use of a compound identified by that process in the preparation of a medicament for therapy of disease, in particular nephropathy, and to diagnostic aspects related to HNOEL-iso polypeptide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663637-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013022599-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010065437-A1 |
| priorityDate |
2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |